Guinea vs Trinidad and Tobago: Previously treated cases tested for RR-/MDR-TB
Guinea
29.0%
in 2024
Trinidad and Tobago
27.0%
in 2024
Guinea rank
161st
Trinidad and Tobago rank
163rd
Previously treated cases tested for RR-/MDR-TB over time
- Guinea
- Trinidad and Tobago
How they compare
Guinea currently reports 29.0% against 27.0% in Trinidad and Tobago, a difference of 2.0%.
That makes Guinea's figure about 1.1 times Trinidad and Tobago's.
The two have swapped places 3 times across 17 shared years of data; in 2005 it was Trinidad and Tobago ahead.
Guinea ranks 161st and Trinidad and Tobago ranks 163rd of 180 countries.
Across the 3 decades both report, Guinea averaged higher in 2 and Trinidad and Tobago in 1.
Head to head by decade
| Decade | Guinea | Trinidad and Tobago | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.9% | 23.3% | 17.4% | Trinidad and Tobago |
| 2010s | 57.9% | 48.4% | 9.4% | Guinea |
| 2020s | 70.8% | 32.0% | 38.8% | Guinea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Guinea or Trinidad and Tobago?
- Guinea, at 29.0% against 27.0% in Trinidad and Tobago as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Guinea and Trinidad and Tobago?
- 2.0%, with Guinea ahead.
- How many years of comparable data are there for Guinea and Trinidad and Tobago?
- 17 years are reported by both, from 2005 to 2024.
- How do Guinea and Trinidad and Tobago rank globally for previously treated cases tested for rr-/mdr-tb?
- Guinea ranks 161st and Trinidad and Tobago ranks 163rd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.